A promising new treatment for recurrent pediatric brain cancer
(Baylor College of Medicine) Researchers developed a novel approach that delivers appropriately-targeted chimeric antigen receptor (CAR) T cell therapy directly into the cerebrospinal fluid that surrounds recurrent pediatric brain tumors.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Baylor College of Medicine | Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | International Medicine & Public Health | Neurology | Pediatrics